Articles
Avancena A, Kahn JG, Marseille E, The costs and health benefits of expanded access to MDMA-assisted therapy for chronic and severe PTSD in the USA: a modeling study. Clinical Drug Investigation, 2022. View in PubMed
Marseille E, Mitchell JM, Kahn, JG. Updated cost-effectiveness of MDMA-assisted therapy for the treatment of PTSD: Findings from a phase 3 trial, PLOS ONE, 2022. View in PubMed
Maya S, Padda G, Close V, Wilson, T Ahmed F, Marseille E, Kahn JG. Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis. BMC, 2022. View in PubMed
Marseille E, Harris A, Horvath H, Parriott A, Malekinejad M, Nelson N, Kahn, JG. Hepatitis B prevalence association with current and past sexually transmitted infections: A systematic review and meta-analysis (1982 2018). Sexual Health, 2021. View in PubMed.
Maya S, Padda G, Close V, Wilson, T Ahmed F, Marseille E, Kahn JG. Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysis. Research Square pre-print. 2021. View in PubMed
Von Kaeppler EP, Kramer EK, Donnelley CA, Wu HH, Marseille E, Eliezer E, Roberts HJ, Shearer D, Morshed S, The Initial Economic Burden of Femur Fractures on Informal Caregivers in Dar es Salaam, Tanzania. Malawi Medical Journal 33 (2);135-139 March 2021 View Online
Shade SB, Marseille E, Kirby V, Chakravarty D, Steward W, Koester K, Cajina A, Myers J. Health information technology interventions and engagement in HIV care and achievement of viral suppression in publicly funded settings in the U.S.: A cost-effectiveness analysis, PLOS Medicine; 2021. View in Pubmed
Marseille E, Yazar-Klosinski, B. Doblin, R, Kahn, JG. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD. PLOS ONE; 2020 . View Online
DeCormier Plosky W, Bollinger L, Alexander L, Cameron DB, Carroll LN, Gomez GB, Levin C, Marseille E, Mustafa M, Siapka M, Vassall, A, Kahn JG. Developing the Global Health Cost Consortium Unit Cost Study Repository for HIV and TB: Methodology and Lessons Learned. African Journal of AIDS Research; 2019. View in PubMed
Cerecero-García D. Pineda-Antunez C, Alexander L, Cameron DB, Martinez-Silva G, Dayo Obure C, Marseille E, Vu L, Kahn JG, Vassall A, Gomez GB, Bollinger L, Levin C, Bautista-Arredondo, S. A meta-analysis approach for estimating average unit costs for ART using pooled facility-level primary data from African countries; in African Journal of AIDS Research; 2019. View in PubMed
Bellamkonda N, Motwani G, Wange A, De Boer C, Juilliard C, Marseille E, Ajiko MM, Dicker RA. “Cost-effectiveness of exploratory laparotomy in a regional referral hospital in Eastern Uganda”; Journal of Surgical Research; 2019. View in Pubmed
Marseille E, Kahn JG. Utilitarianism, and the Ethical Foundations of Cost-effectiveness Analysis in Resource Allocation for Global Health, in Philosophy, Ethics and Humanities in Medicine, 2019. View Online
Cameron DB, Mustafa M, Carroll LN, Bollinger L, DeCormier Plosky W, Levin C, Herzel B, Bautista-Arredondo S, Pineda C, Cerecero D, Gomez G, Marseille E, Dow WH, Kahn JG. The state of costing research for HIV interventions in sub-Saharan Africa. African Journal of AIDS Research, 2019. View in PubMed.
Marseille E, Mirzazadeh A, Biggs A, Viitanen A, Horvath H, Lightfoot M, Malekinajad M, Kahn JG. School-based interventions to reduce the risk of pregnancy in high-risk youth in the United States: A systematic review and meta-analysis. Prevention Science, January 2018. View Online
Kortz TB, Herzel B, Marseille E, Kahn JG. “Bubble continuous positive airway pressure in the treatment of severe pediatric pneumonia in Malawi: a cost-effectiveness analysis” British Medical Journal, July 20, 2017. View online
Mirzazadeh A, Biggs A, Viitanen A, Horvath H, Wang LY, Dunville R, Barrios L, Kahn JG, Marseille E. Do school-based programs prevent HIV and other sexually transmitted infections in adolescents? A systematic review and meta-analysis. Prevention Science, August, 2017. View Online
Marseille E, Kahn JG. A revolution in treatment for Hepatitis C infection: Mitigating the budgetary impact. Plos Medicine, May, 2016. View Online
Kramer EJ, Shearer DW, Marseille E, Haonga B, Ngahyoma J, Eliezer E, Saam Morshed S. The Cost of Intramedullary Nailing for Femoral Shaft Fractures in Dar es Salaam, Tanzania. World Journal of Surgery, March, 2016. View in Pubmed
Jain V, Chang W, Byonanebye DM, Owaraganise A, Twinomuhwezi E, Amanyire G, Black D, Marseille E, Kamya MR, Havlir DR, Kahn JG, and the SEARCH Collaboration. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ Counts (>350 cells/uL) in Rural Uganda. PLoS One, December, 2015. View in Pubmed
Chahal HS, Marseille E, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of early treatment for Hepatitis C virus genotype 1 by stage of liver fibrosis in US treatment-naïve populations. JAMA Internal Medicine, November, 2015. View Online
Verguet S, Kahn JG, Marseille E, Jiwani A, Kern E, Walson JL, Are long-lasting insecticide-treated bednets and water filters cost-effective tools for delaying HIV disease progression in Kenya? Global Health Action, June, 2015. View in Pubmed
Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost–effectiveness of interventions: alternative approaches. Bulletin of the World Health Organization, February, 2015. View on Pubmed
Weile LK, Kahn JG, Marseille E, Jensen DM, Damm P, Lohse N. Global cost-effectiveness of GDM screening and management: Current knowledge and future needs. Best Practices and Research, Clinical Obstetrics and Gynaecology, Vol 29, Issue 2, pp 206-224, 2015. View in PubMed.
Marseille E, Kahn JG. ‘Prevention as Prevention’ is Cost-effective: Commentary on the cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in South India. Lancet Global Health, September, 2014. View Online
Marseille E, Jiwani A, Raut A, Verguet S, Walson J, Kahn JG. Scaling up integrated prevention campaigns for global health: Costs and cost-effectiveness in 70 countries. British Medical Journal-Open, June 2014. View Online
Marseille E, Morshed S. Editorial: Comment on Policy Implications for Surgery in Global Health: Essential surgery is cost effective in resource-poor countries. The Lancet Global Health, Volume 2, Issue 6, Pages e302 - e303, June, 2014
Koethe JR, Marseille E, Giganti MJ, Chi BH, Heimburger D, Stringer JS. Estimating the cost-effectiveness of nutrition supplementation for malnourished, HIV-infected adults starting antiretroviral therapy in a resource-constrained setting. Cost Effectiveness and Resource Allocation, 12; 2014. View Online
Jiwani A, Matheson A, Kahn JG, Raut A, Verguet S, Marseille E, Walson, J. Integrated disease prevention campaigns: assessing country opportunity for implementation via an index approach. British Medical Journal Open - Health Services Research, March, 2014 View Online
Marseille E, Kahn JG, Beatty S, Perchal P. Adult male circumcision in Nyanza, Kenya: the cost and efficiency of alternative service delivery modes, BMC Health Services Research, 14:33; Jan. 2014. View Online
Gabrielle E O'Malley, Marseille E, Weaver MR. Cost and cost-effectiveness analyses of global HIV training programs. Human Resources for Health, 2013. View Online
Kahn JG, Marseille E. Capsule commentary on Long and Stavert, Portfolios of Biomedical HI Interventions in South Africa: A cost-effectiveness analysis. Journal of General Internal medicine. July, 2013. View Online
Kahn JG, Marseille E. Viral load monitoring for antiretroviral therapy in resource-poor settings: an evolving role, AIDS; 27:1509–1511, 2013. View Online
Marseille, E., N. Lohse, et al. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med., 2013. View Online
Marseille E, Giganti M, Mwango, A et al. Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia. Plos One; 2012; 7(12): e51993. View Online
Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: Global prevalence and response - results from a survey of country practices. Journal of Maternal-Fetal & Neonatal Medicine. 2012; 25(6): 600-10. View Online
Lohse N, Marseille E, Kahn JG. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for prevention of type 2 diabetes mellitus. International Journal of Gynecology and Obstetrics. 115 Suppl. 1 (2011) S20–S25. View on Pubmed
Marseille E, Kevany S, Ahmed I, Feleke G, Graham B, Heller T, Kahn JG, Reyes M. Case management to improve adherence in HIV-infected patients receiving antiretroviral therapy in Ethiopia: A micro-costing study. Cost-Effectiveness and Resource Allocation, 2011, 9:18. View Online
Kahn JG, Marseille E, Moore D, Bunnell, R, Were W, Degerman R, Tappero, JW, Ekwaru, P, Kaharuza F, Mermin J. Cost-Effectiveness of CD4 cell count and Viral Load Monitoring of Antiretroviral Therapy in Uganda. British Medical Journal. 343:d6884, November 2011. View on Pubmed
Kahn JG, Marseille E, Bennett R, Williams BG, Granich R. Cost-Effectiveness of Antiretroviral Therapy for Prevention. Current HIV Research. Volume 9, Number 6, September 2011, pp. 405-415(11) View Online
Marseille E, Shade S, Myers, J, Dawson C, Koester K, Maiorana A, Malitz, F, Bie J, Morin, S. The Cost-Effectiveness of HIV Prevention Interventions for HIV-Infected Patients Seen in Clinical Settings. JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(3):e87-e94, March, 2011
Marseille E, Kahn JG, Pitter C, Bunnell R, Epalatai W, Were W, and Mermin J. The Cost-Effectiveness of Home-Based Provision of Antiretroviral Therapy in Rural Uganda, Applied Health Economics and Health Policy. 7: 229-243, November, 2009. View Online
Potts M, Halperin D, Walsh J, Kirby D, Klausner J, Marseille E, Swidler A, Hearst N, Wamai R, Kahn, JG. Reassessing HIV prevention. Science. 2008; 320: 749–750.
Auvert B, Marseille E, Korenromp EL, Lloyd-Smith J, Sitta R, Taljaard D, Pretorius C, Williams B, Kahn JG. Estimating the Resources Needed and Savings Anticipated from Roll-out of Adult Male Circumcision in Sub-Saharan Africa. PLoS ONE Public Library of Science. 2008;3(8):e2679. View Online
Dandona L, Kumar SGP, Ramesh YK, Rao MC, Kumar AA, Marseille E, Kahn JG, Dandona R. Changing cost of HIV interventions in the context of scaling-up in India. AIDS. 2008; 22 (suppl 1): S43-S49. View on Pubmed
Dandona L, Kumar SGP, Ramesh YK, Kumar AA, Rao MC, Marseille E, Kahn JG, Dandona R. Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India: BMC Public Health Services Research. 8(26): January, 2008. View Online
Marseille E, Dandona, L, Marshall N, Gaist P, et al. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries BMC Health Services Research. Vol. 7, No. 108, July, 2007. View Online
Kahn JG, Marseille E, Auvert B. Circumcision for HIV Prevention: Authors' Reply. PLoS Medicine. 4(3): March, 2007. View in PubMed
Pitter CS, Kahn JG, Marseille E, Lule JR, McFarland DA, Ekwaru JP, Bunnell R, Coutinho A, Mermin J. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. Journal of Acquired Immune Deficiency Syndrome. Vol. 44, No. 3, March, 2007. View on Pubmed
Flaherman VJ, Porco TC, Marseille E Royce SE. Cost-Effectiveness of Alternative Strategies for Tuberculosis Screening Prior to Kindergarten Entry. Pediatrics. Vol. 120, No. 1, July, 2007. View on Pubmed
Over M, Marseille E, Sudhakar K, Gold J, Gupta I, Indrayan A, Hira S, Nagelkerke N, Rao S, Heywood P. Antiretroviral therapy and HIV prevention in India: Modeling costs and consequences of policy options. Sexually Transmitted Diseases. Vol. 33, No. 10, October Supplement 2006. View Online
Kahn JG, Marseille E, Auvert B. Cost-Effectiveness of Male Circumcision for HIV Prevention in a South African Setting PLoS Medicine. 3: 12, 2006 View on Pubmed
Porco TC, Lewis B, Marseille E, Grinsdale J, Flood JM, Royce SE. Cost-effectiveness of tuberculosis evaluation and treatment of newly arrived immigrants. BMC Public Health. 6:157, 2006. View on Pubmed
Marseille E, Kahn JG, Muyingo S, Saba J. The Costs and Benefits of Private Sector Provision of Treatment to HIV-Infected Employees in Kampala, Uganda. AIDS. 20: 907 – 914, 2006. View on Pubmed
Shrestha RK, Marseille E, Kahn JG Lule JR, Pitter C, Blandford JM, Bunnell R, Mermin J. The Cost-Effectiveness of Home-Based Chlorination and Safe Water Storage in Reducing Diarrhea among HIV-Affected Households in Rural Uganda. Journal of Tropical Medicine and Hygiene. Vol. 74, No. 5, 2006. View Online
McConnell CE, Stanley N, du Plessis J, Pitter CS, Abdulla F, Coovadia HM, Marseille E, Kahn JG. The cost of a rapid-test VCT clinic in South Africa. South African Medical Journal. Vol. 95, No. 12 pp. 968 – 971, December, 2005.
Dandona L, Sisodia P, Prasad TL, Marseille E, Kumar SGP, Kumar AA, Rao MC, Ramesh YK, Over M, Someshwar M, Kahn JG. Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India. BMC Public Health 2005. 5:69
Dandona L, Sisodia P, Kumar SGP, Ramesh YK, Kumar AA, Rao MC, Marseille E, Someshwar M, Marshall N, Kahn JG. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency BMC Public Health. 2005, 5:98 View Online
Dandona L, Sisodia P, Ramesh YK, Kumar SGP, Kumar AA, Rao MC, Someshwar M, Hansl B, Marshall N, Marseille E, Kahn JG. Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India. National Medical Journal of India. January – February, 2005. View Online
Marseille E, Dandona L, Saba J, McConnel C, Rollins B, Gaist P, Lundberg M, Over M, Bertozzi S, Kahn JG. Assessing the Efficiency of HIV Prevention around the World: Methods of the PANCEA project, Health Services Research. December, 2004. View online
Over M, Gold J, Gupta I, Indrayan A, Hira S, Kurapati S, Marseille E, Nagelkerke N, Rao SR, Heywood P. HIV/AIDS Treatment and Prevention in India: Costs and Consequences of Policy Options. Book and CD, World Bank, July, 2004. View Online
Marseille E. The External Effects of HAART, A Background Paper for HIV/AIDS Treatment and Prevention in India. Washington, DC: World Bank, 2003. View Online
Marseille E. The Opportunity Cost of Government Resources Used for HAART, A Background Paper for HIV/AIDS Treatment and Prevention in India. Washington, DC: World Bank, 2003. View Online
Stringer J, Rouse D, Sinkala M, Marseille E, Vermund S, Stringer E, Goldenberg R. Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus. Lancet, Vol. 362: p. 1850-3, November 29, 2003. View in PubMed
Marseille E, Hofmann PB, Kahn JG. HIV prevention before HAART in sub-Saharan Africa. Lancet, Vol. 359: p. 1851-6, May 25, 2002. View in Pubmed
Kahn JG and Marseille E. A saga in international HIV policy modeling: preventing mother to-child HIV transmission. Journal of Policy and Management, Vol. 21, No. 3, pp. 499-505, Summer 2002. View in Pubmed
Marseille E, Kahn JG, Saba J. Cost-Effectiveness of the Female Condom in Preventing HIV and STDs in Commercial Sex Workers in Rural South Africa, Social Science and Medicine. November, 2000. View in Pubmed
Marseille E, Kahn JG, Guay, L, Jackson JB. The Cost-Effectiveness of a Single-Dose Nevirapine Regimen to Mother and Infant to Reduce Vertical HIV-1 Transmission in Sub-Saharan Africa, in Prevention and Treatment of HIV Infections in Infants and Children, Arthur Amman and Arye Rubenstein, co-editors, New York Academy of Sciences, New York City, New York, June, 2000. View in Pubmed
Marseille E, Kahn JG, Mmiro F, Guay L, Fowler MG, Jackson JB. HIVNET 012 Nevirapine Trials, Lancet, [Letter], Vol. 354:9192; November 20, 1999. View Online
Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa, in Lancet, Vol. 354:9191; September 4, 1999. View on Pubmed
Kahn JG, Marseille E, Saba J. Feeding Strategies of HIV-Infected Mothers: Modeling the Trade-Off between HIV Infection and non-HIV Mortality, in Quantitative Analysis of HIV Policy, Kaplan E, Brookmeyer R, editors; New Haven, Yale Press; 1999. View Online
Marseille E, Kahn JG, Saba J. The Cost Effectiveness of Antiviral Therapy to Reduce Mother-to-Child Transmission of HIV in Sub-Saharan Africa, AIDS. May, 1998. View on Pubmed
Marseille E, Brand R. The Distribution of Cataract Services in a Public Health Eye Care Program in Nepal, Health Policy. Vol. 42: 2, 1997. View Online
Marseille E. The Cost-Effectiveness of Cataract Surgery in a Public Health Eye Care Program in Nepal, Bulletin of the World Health Organization. Vol. 74:3, 1996. View Online
Marseille E, Gilbert S. The Cost of Cataract Surgery in a Public Health Eye Care Program in Nepal, Health Policy. Vol. 352: 2, February, 1996. View in PubMed
Erpelding A, Marseille E. From Darkness to Light: The Health Education Campaign of the Nepal Blindness Program, Community Eye Health. Vol. 6:12, 1993.